OppenheimerFunds’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$36.3M Buy
652,008
+39,240
+6% +$2.4M 0.05% 394
2018
Q4
$30.4M Buy
612,768
+66,645
+12% +$4.08M 0.04% 402
2018
Q3
$47.2M Buy
546,123
+198,794
+57% +$14.2M 0.05% 349
2018
Q2
$20.2M Buy
+347,329
New +$17M 0.02% 579
2015
Q4
Sell
-228,850
Closed -$5.1M 1762
2015
Q3
$5.1M Buy
+228,850
New +$6.18M 0.01% 813

Other funds holding TDOC

OppenheimerFunds's TDOC Position: Q1 2019 in Review

OppenheimerFunds increased its Teladoc Health (TDOC) stake by 6.4% in Q1 2019, buying an estimated $2.4M and bringing the position to 652,008 shares worth $36.3M. The position accounts for 0.05% of the portfolio, ranked #394.

OppenheimerFunds first reported a position in TDOC in Q3 2015 and has held it in 5 quarters since. The position peaked at $47.2M in Q3 2018. 364 funds tracked by Wall St. Rank hold TDOC as of Q1 2019.

  • OppenheimerFunds held 652,008 shares of Teladoc Health worth $36.3M as of Q1 2019.
  • OppenheimerFunds bought 39,240 Teladoc Health shares in Q1 2019, an estimated $2.4M.
  • Teladoc Health made up 0.05% of OppenheimerFunds's portfolio in Q1 2019, its #394 holding.
  • OppenheimerFunds first reported a position in Teladoc Health in Q3 2015 and has held it in 5 quarters since.
  • OppenheimerFunds's Teladoc Health position peaked at $47.2M in Q3 2018.
  • 364 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.